RxDoctor Payments Data

Daniellle Seiner

Family · Bolivar, MONPI 1851737225

Payments from drug & device makers

$1,793in general payments, 2019–2025

Across 95 payments — averaging $18.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$345
  • AstraZeneca$285
  • AbbVie$197
  • Novo Nordisk$135
  • GSK$102
  • Eisai Inc.$85
  • plus $644 from 18 others

What the payments were for

  • Food & beverage$1,793100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,793 in reported general payments places this provider in the 75th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban41$26,536
JardianceEmpagliflozin22$26,389
LinzessLinaclotide18$23,965
OzempicSemaglutide21$18,703
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$14,713
MounjaroTirzepatide13$14,302
EntrestoSacubitril/Valsartan15$9,577
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog12$3,335
Albuterol Sulfate HfaAlbuterol Sulfate82$2,002
Gabapentin154$1,873
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$1,864
Duloxetine Hcl98$1,582
Omeprazole145$1,538
Potassium Chloride93$1,524
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate15$1,198

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$197$23,96518 claims
Novo NordiskOzempic$135$18,70321 claims
GSKTrelegy Ellipta$102$14,71315 claims
Lilly USA, LLCMounjaro$345$14,30213 claims
NovartisEntresto$31$9,57715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,812 family providers in Missouri.

Other family in Bolivar

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →